U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07121972) titled 'Mirai-MRI: Validation of AI Models for Breast Cancer Risk' on Aug. 06.
Brief Summary: This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
Study Start Date: Aug. 10
Study Type: INTERVENTIONAL
Condition:
Cancer Risk
Breast Cancer Risk
Intervention:
PROCEDURE: Magnetic resonance imaging (MRI)
Undergo Magnetic resonance (MR) imaging
DEVICE: Artificial Intelligence (AI)
AI applied to MRI images
Recruitment Stat...